SymBio Pharmaceuticals Limited Current Assets

SymBio Pharmaceuticals Limited (SYMQY) currently reports a current assets of $1.9B as of June 2026. That compares with $4.1B in the prior-year period — down 54.7% year over year. Use the charts on this page to explore SymBio Pharmaceuticals Limited's current assets history and peer comparisons.

SymBio Pharmaceuticals Limited's current assets decreased from $4.1B to $1.9B — a 54.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SymBio Pharmaceuticals Limited reported $1.9B in current assets as of June 2026. That compares with $4.1B in the prior-year period — down 54.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $1.9B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SymBio Pharmaceuticals Limited, and consider following SYMQY for alerts when major investors trade the stock.